Canopy's DOJA facility now a medical cultivation site

Executive Summary

• Canopy Growth’s DOJA facility in Kelowna, B.C., is now operating exclusively as a medical‑cannabis cultivation site for the Spectrum Therapeutics portfolio.
• The plant will produce small‑batch, craft‑style cannabis under the DOJA brand, sold only to registered Spectrum Therapeutics medical patients in Canada.
• The transition follows an upgrade to a new micro‑cultivation licence and underscores Canopy’s long‑term focus on the Canadian medical market.

Key Details

• Facility Conversion: The Kelowna DOJA site has been re‑licensed as a “micro‑cultivation” operation dedicated solely to medical cannabis production.
• Product Offering: Small‑batch, British Columbia‑grown craft cannabis will be marketed under the DOJA brand and made available exclusively to Spectrum Therapeutics’ registered medical patients, including veterans.
• Strategic Rationale: CEO Luc Mongeau highlighted the move as part of Canopy Growth’s transformation toward a stronger, more sustainable Canadian medical business.
• Executive Commentary: Andrew Bevan, SVP Global Medical, described DOJA as a “distinct commercial opportunity” that enhances Spectrum’s leadership in Canada’s medical market.
• Patient Access: Registered Spectrum Therapeutics patients can obtain information on DOJA flower strains via the Spectrum Therapeutics website.

Notable Quotes

“As we advance Canopy Growth's transformation, Canada's medical market continues to be a standout business for us,” – Luc Mongeau, CEO
“DOJA represents a distinct commercial opportunity for Canopy Growth's Canadian medical business… enhances our portfolio and reinforces Spectrum's leadership in Canada's medical market.” – Andrew Bevan, SVP Global Medical